FierceBiotech 2026-01-09 Quanterix nabs Illumina’s CCO as new leader, but Leerink warns of ‘significant lift’ needed for turnaround
FierceBiotech 2026-01-09 Madrigal pays $50M for Pfizer MASH drug with eye on Rezdiffra combo potential
Roche Media 2026-01-09 Former Roche oncology head turns to Tubulis—Chutes & Ladders - fiercebiotech.com
FierceBiotech 2026-01-09 Illumina hires former NHGRI Director Eric Green as new chief medical officer
FierceBiotech 2026-01-09 Roche returns to MediLink with promise of $570M near-term payments for another ADC
FierceBiotech 2026-01-09 Ollin eyes phase 3 after bispecific tops Vabysmo in early-stage trial, clearing more retinal disease faster
FierceBiotech 2026-01-08 Longtime Charles River leader Jim Foster to retire, with COO set to take the helm
FierceBiotech 2026-01-08 Lexeo Therapeutics, J&J team up to test heart pump technology for cardiac gene therapy delivery
FierceBiotech 2026-01-08 Immuneering touts 64% 1-year survival, keeping wheels turning in race with Revolution
FierceBiotech 2026-01-08 Diagonal moves forward with $125M series B round, plots first-in-human study this year
FierceBiotech 2026-01-08 WEP Clinical grabs European CRO Siron Clinical, broadening global capabilities